The Children's Hospital University of Illinois
No posts currently available to show
Northwestern University - Ann and Robert H. Lurie Children's Hospital of Chicago
No posts currently available to show
Medical College of Wisconsin - Children's Hospital of Wisconsin
No posts currently available to show
Rush University Children's Hospital
No posts currently available to show
University of Chicago - Comer Children's Hospital
No posts currently available to show
University of Iowa - Stead Family Children's Hospital
No posts currently available to show
University of Minnesota - Masonic Children's Hospital
MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
This single-institution, phase II study is designed to test the ability to achieve donor hematopoietic engraftment while maintaining low rates of transplant-related mortality (TRM) using busulfan- and fludarabine-based conditioning regimens with busulfan therapeutic drug monitoring (TDM) for patients with various inherited metabolic disorders (IMD) and severe osteopetrosis (OP).
August 4, 2020- More Osteopetrosis - University of Minnesota - Masonic Children's Hospital posts
University of Wisconsin - American Family Children's Hospital
No posts currently available to show